Template:Cytokine receptor modulators: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import Tags: mobile edit mobile web edit |
m 1 revision imported |
||
| (One intermediate revision by one other user not shown) | |||
| Line 151: | Line 151: | ||
| group1 = [[JAK1]] | | group1 = [[JAK1]] | ||
| list1 = | | list1 = | ||
* [[Abrocitinib]] | |||
* [[Baricitinib]] | * [[Baricitinib]] | ||
* [[Deuruxolitinib]] | |||
* [[Filgotinib]] | * [[Filgotinib]] | ||
* [[Momelotinib]] | * [[Momelotinib]] | ||
* [[Oclacitinib]] | * [[Oclacitinib]] | ||
* [[Peficitinib]] | |||
* [[Ruxolitinib]] | * [[Ruxolitinib]] | ||
* [[Tofacitinib|Tofacitinib (tasocitinib | * [[Tofacitinib|Tofacitinib (tasocitinib)]] | ||
* [[Upadacitinib]] | * [[Upadacitinib]] | ||
| group2 = [[JAK2]] | | group2 = [[JAK2]] | ||
| list2 = | | list2 = | ||
* [[Atiprimod]] | * [[Atiprimod]] | ||
* [[AZD-1480]] | * [[AZD-1480]] | ||
| Line 168: | Line 170: | ||
* [[Cucurbitacin I|Cucurbitacin I (elatericin B, JSI-124)]] | * [[Cucurbitacin I|Cucurbitacin I (elatericin B, JSI-124)]] | ||
* [[CYT387]] | * [[CYT387]] | ||
* [[Deuruxolitinib]] | |||
* [[Lestaurtinib]] | * [[Lestaurtinib]] | ||
* [[NSC-7908]] | * [[NSC-7908]] | ||
* [[NSC-33994]] | * [[NSC-33994]] | ||
* [[Pacritinib]] | * [[Pacritinib]] | ||
* [[Peficitinib]] | |||
* [[Ruxolitinib]] | * [[Ruxolitinib]] | ||
* [[SD-1008]] | * [[SD-1008]] | ||
* [[Tofacitinib|Tofacitinib (tasocitinib | * [[Tofacitinib|Tofacitinib (tasocitinib)]] | ||
| group3 = [[JAK3]] | | group3 = [[JAK3]] | ||
| list3 = | | list3 = | ||
* [[Cercosporamide]] | * [[Cercosporamide]] | ||
* [[Decernotinib|Decernotinib (VX-509)]] | * [[Decernotinib|Decernotinib (VX-509)]] | ||
* [[Peficitinib]] | |||
* [[Ritlecitinib]] | |||
* [[TCS-21311]] | * [[TCS-21311]] | ||
* [[Tofacitinib|Tofacitinib (tasocitinib | * [[Tofacitinib|Tofacitinib (tasocitinib)]] | ||
* [[WHI-P 154]] | * [[WHI-P 154]] | ||
* [[ZM-39923]] | * [[ZM-39923]] | ||
* [[ZM-449829]] | * [[ZM-449829]] | ||
| group4 = [[ | | group4 = [[Tyrosine kinase 2|TYK2]] | ||
| list4 = | | list4 = | ||
* [[Deucravacitinib]] | |||
}} | }} | ||
| Line 208: | Line 214: | ||
}} | }} | ||
}}<noinclude> | }}<noinclude> | ||
| Line 219: | Line 219: | ||
[[Category:Drug templates by receptor, channel, or pump]] | [[Category:Drug templates by receptor, channel, or pump]] | ||
</noinclude> | </noinclude> | ||
